Artificial Intelligence helps identify Diabetic Retinopathy and Clinically Significant Diabetic Macular Edema

July 30, 2019. Chicago, IL: The results of a prospective study, titled “Artificial Intelligence Screening for Diabetic Retinopathy: Analysis from a Pivotal Multi-center Prospective Clinical Trial,” were presented at the 37TH American Society of Retina Specialists Annual Meeting by Jennifer Lim, MD (professor of ophthalmology and director of the Retina Service at University of Illinois Eye and Ear Infirmary), demonstrating that EyeArt® System has high enough sensitivity and specificity to detect moderate non-proliferative or clinically significant Diabetic Macular Edema.

View the results and  full article here: https://www.mdmag.com/conference-coverage/asrs-2019/using-ai-to-identify-diabetic-retinopathy-and-clinically-significant-dme

Share This Post